Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06623422
PHASE3

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Sponsor: Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

Summary

The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want to know if giving intismeran autogene and pembrolizumab after surgery can help prevent the cancer from coming back in people with non-small cell lung cancer (NSCLC) whose tumors did not respond completely to treatment before surgery (neoadjuvant treatment).

Official title: A Phase 3 Randomized Double-blind Study of Adjuvant Pembrolizumab With or Without V940 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy (INTerpath-009)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

680

Start Date

2024-10-21

Completion Date

2038-01-26

Last Updated

2026-10-30

Healthy Volunteers

No

Interventions

BIOLOGICAL

Pembrolizumab

IV Infusion

DRUG

Cisplatin

IV infusion

DRUG

Carboplatin

IV infusion

DRUG

Pemetrexed

IV infusion

DRUG

Gemcitabine

IV infusion

DRUG

Paclitaxel

IV infusion

BIOLOGICAL

Intismeran autogene

IM injection

OTHER

Placebo

IM injection

Locations (245)

Banner MD Anderson Cancer Center ( Site 0181)

Gilbert, Arizona, United States

The University of Arizona Cancer Center - North Campus ( Site 0163)

Tucson, Arizona, United States

Providence St. Jude Medical Center ( Site 0106)

Fullerton, California, United States

VA Long Beach Healthcare System ( Site 0199)

Long Beach, California, United States

USC Norris Comprehensive Cancer Center ( Site 0205)

Los Angeles, California, United States

UCLA Jonsson Comprehensive Cancer Center ( Site 0135)

Los Angeles, California, United States

UCSF Medical Center at Mission Bay ( Site 0178)

San Francisco, California, United States

University of Colorado Anschutz Medical Campus ( Site 0151)

Aurora, Colorado, United States

UCHealth Memorial Hospital Central ( Site 0125)

Colorado Springs, Colorado, United States

Banner MD Anderson Cancer Center at North Colorado Medical Center ( Site 0207)

Greeley, Colorado, United States

Centura Health - St. Anthony North Health Campus ( Site 0189)

Westminster, Colorado, United States

Yale University School of Medicine ( Site 0201)

New Haven, Connecticut, United States

Eastern CT Hematology & Oncology Associates ( Site 0202)

Norwich, Connecticut, United States

The Oncology Institute of Hope and Innovation - Fort Lauderdale ( Site 0156)

Fort Lauderdale, Florida, United States

Miami Cancer Institute at Baptist Health, Inc. ( Site 0214)

Miami, Florida, United States

Beacon Cancer Care ( Site 0127)

Post Falls, Idaho, United States

The University of Chicago Medical Center ( Site 0118)

Chicago, Illinois, United States

Illinois Cancer Care ( Site 8107)

Peoria, Illinois, United States

Franciscan Health ( Site 0219)

Indianapolis, Indiana, United States

Maryland Oncology Hematology (MOH) ( Site 8102)

Rockville, Maryland, United States

Massachusetts General Hospital ( Site 0136)

Boston, Massachusetts, United States

Dana Farber Cancer Hospital ( Site 0155)

Boston, Massachusetts, United States

Ellis Fischel Cancer Center ( Site 0133)

Columbia, Missouri, United States

Lake Regional Hospital-Cancer Center ( Site 0123)

Osage Beach, Missouri, United States

Roswell Park Cancer Institute ( Site 0184)

Buffalo, New York, United States

Hematology-Oncology Associates of CNY ( Site 0164)

East Syracuse, New York, United States

The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0216)

New York, New York, United States

Icahn School of Medicine at Mount Sinai ( Site 0116)

New York, New York, United States

Memorial Sloan Kettering Cancer Center ( Site 0137)

New York, New York, United States

SUNY Upstate Cancer Center ( Site 0140)

Syracuse, New York, United States

Montefiore Medical Center ( Site 0160)

The Bronx, New York, United States

Westchester Medical Center ( Site 0196)

Valhalla, New York, United States

Novant Health Weisiger Cancer Insititute ( Site 0266)

Charlotte, North Carolina, United States

Novant Health Forsyth Medical Center ( Site 0166)

Winston-Salem, North Carolina, United States

University of Cincinnati Medical Center ( Site 0119)

Cincinnati, Ohio, United States

Good Samaritan Regional Medical Center-Samaritan Pastega Regional Cancer Center ( Site 0217)

Corvallis, Oregon, United States

St. Lukes Hospital and Health Network ( Site 0186)

Bethlehem, Pennsylvania, United States

Tennessee Oncology, PLLC - Chattanooga Downtown ( Site 0315)

Chattanooga, Tennessee, United States

Thompson Cancer Survival Center ( Site 0168)

Knoxville, Tennessee, United States

Baptist Clinical Research Institute, Inc. ( Site 9501)

Memphis, Tennessee, United States

Elliston Place Medical Oncology & Hematology ( Site 0215)

Nashville, Tennessee, United States

Texas Oncology - DFW ( Site 8103)

Dallas, Texas, United States

UT Southwestern Medical Center ( Site 0190)

Dallas, Texas, United States

Houston Methodist Cancer Center ( Site 0191)

Houston, Texas, United States

MD Anderson Cancer Center ( Site 0150)

Houston, Texas, United States

Memorial Hermann Cancer Center ( Site 0172)

Houston, Texas, United States

Michael E. DeBakey VA Medical Center ( Site 0197)

Houston, Texas, United States

O'Quinn Medical Tower at McNair Campus ( Site 0131)

Houston, Texas, United States

The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0148)

Tyler, Texas, United States

Virginia Cancer Specialists ( Site 0167)

Fairfax, Virginia, United States

Virginia Oncology Associates (VOA) ( Site 8101)

Norfolk, Virginia, United States

VCU Health Adult Outpatient Pavillion ( Site 0193)

Richmond, Virginia, United States

Swedish Cancer Institute ( Site 0143)

Seattle, Washington, United States

St. Joseph Medical Center Hematology and Oncology - Silverdale ( Site 0192)

Silverdale, Washington, United States

CEMIC ( Site 2454)

Caba., Buenos Aires, Argentina

Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 2459)

Ciudad Autonoma de Buenos Aires., Buenos Aires, Argentina

Fundacion Intecnus ( Site 2456)

Bariloche, Río Negro Province, Argentina

Centro Médico IPAM ( Site 2452)

Rosario, Santa Fe Province, Argentina

Instituto Medico Especializado Alexander Fleming ( Site 2457)

Buenos Aires, Argentina

Instituto Oncologico de Cordoba -IONC ( Site 2455)

Córdoba, Argentina

Calvary Mater Newcastle ( Site 2106)

Waratah, New South Wales, Australia

Tasman Oncology Research ( Site 2104)

Southport, Queensland, Australia

Princess Alexandra Hospital ( Site 2102)

Woolloongabba, Queensland, Australia

Grampians Health ( Site 2101)

Ballarat, Victoria, Australia

One Clinical Research ( Site 2103)

Nedlands, Western Australia, Australia

Cliniques Universitaires Saint-Luc ( Site 1203)

Brussels, Bruxelles-Capitale, Region de, Belgium

Jessa Ziekenhuis ( Site 1204)

Hasselt, Limburg, Belgium

UZ Gent ( Site 1201)

Ghent, Oost-Vlaanderen, Belgium

CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA ( Site 2502)

Fortaleza, Ceará, Brazil

Hospital Araújo Jorge ( Site 2514)

Goiânia, Goiás, Brazil

Liga Norte Riograndense Contra o Cancer ( Site 2513)

Natal, Rio Grande do Norte, Brazil

Hospital Tacchini ( Site 2506)

Bento Gonçalves, Rio Grande do Sul, Brazil

Hospital de Clínicas de Passo Fundo ( Site 2504)

Passo Fundo, Rio Grande do Sul, Brazil

Hospital Moinhos de Vento ( Site 2510)

Porto Alegre, Rio Grande do Sul, Brazil

Hospital Nossa Senhora Da Conceicao ( Site 2512)

Porto Alegre, Rio Grande do Sul, Brazil

Instituto de Oncologia Saint Gallen ( Site 2507)

Santa Cruz do Sul, Rio Grande do Sul, Brazil

Hospital de Amor - Barretos ( Site 2511)

Barretos, São Paulo, Brazil

Instituto Nacional de Câncer - INCA ( Site 2501)

Rio de Janeiro, Brazil

MBAL Uni Hospital ( Site 1253)

Panagyurishte, Pazardzhik, Bulgaria

MHAT - Heart and Brain ( Site 1252)

Pleven, Bulgaria

Queen Elizabeth II Health Sciences Centre ( Site 1101)

Halifax, Nova Scotia, Canada

Hamilton Health Sciences - Juravinski Site ( Site 1104)

Hamilton, Ontario, Canada

Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 1105)

Kingston, Ontario, Canada

Lakeridge Health ( Site 1107)

Oshawa, Ontario, Canada

Sunnybrook Research Institute ( Site 1106)

Toronto, Ontario, Canada

McGill University Health Centre ( Site 1103)

Montreal, Quebec, Canada

IUCPQ ( Site 1112)

Québec, Quebec, Canada

Orlandi Oncologia ( Site 2555)

Santiago, Region M. de Santiago, Chile

Fundación Arturo López Pérez ( Site 2551)

Santiago, Region M. de Santiago, Chile

Clínica RedSalud Vitacura ( Site 2556)

Santiago, Region M. de Santiago, Chile

Bradfordhill ( Site 2552)

Santiago, Region M. de Santiago, Chile

ONCOCENTRO APYS ( Site 2554)

Viña del Mar, Valparaiso, Chile

Bradford Hill Norte ( Site 2563)

Antofagasta, Chile

FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 2603)

Bogotá, Bogota D.C., Colombia

Hospital Universitario San Ignacio ( Site 2610)

Bogotá, Bogota D.C., Colombia

Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 2604)

Bogotá, Bogota D.C., Colombia

IMAT S.A.S ( Site 2602)

Montería, Departamento de Córdoba, Colombia

Oncologos del Occidente ( Site 2608)

Pereira, Risaralda Department, Colombia

Fundacion Valle del Lili- CIC ( Site 2601)

Cali, Valle del Cauca Department, Colombia

Oulun yliopistollinen sairaala ( Site 1301)

Oulu, Northern Savonia, Finland

And 145 more locations on ClinicalTrials.gov